Prevalence of von Willebrand disease in women with iron deficiency anaemia and menorrhagia in Taiwan

Haemophilia

Volumn 14, Issue 4, 2008, Pages 768-774

  Chen, Yeu Chin ^a,c   Chao, T Y ^a   Cheng, S N ^a   Hu, S H ^a   Liu, J Y ^b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Iron deficiency anaemia; Menorrhagia; von Willebrand disease

Indexed keywords

ATOFEN; FERRIC CHLORIDE; FERRIC OXIDE; FERRITIN; FERROUS SULFATE; HEMOGLOBIN; TRANSFERRIN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLEEDING TIME; CONSTIPATION; CONTROLLED STUDY; DRUG TOLERABILITY; EPIGASTRIC PAIN; FEMALE; FOLLOW UP; HUMAN; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MENORRHAGIA; ONSET AGE; PREMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; RECURRENCE RISK; TAIWAN; THROMBOCYTE FUNCTION; VON WILLEBRAND DISEASE;

ADOLESCENT; ADULT; AGE FACTORS; ANEMIA, IRON-DEFICIENCY; DIETARY SUPPLEMENTS; FEMALE; HUMANS; IRON; MENORRHAGIA; MIDDLE AGED; PLATELET FUNCTION TESTS; PREMENOPAUSE; RECURRENCE; TAIWAN; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR; YOUNG ADULT;

EID: 47649116782     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01777.x     Document Type: Article

References (28)

1. Rees M. Menorrhagia. BMJ 1987; 294: 759-62.
2. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand disease. Blood 1987; 69: 454-9.
3. Werner JE, Broxson EH, Tucker EL, Biroox DS, Shults J, Abshire TC. Prevalence of von Willebrand's disease in children: A multiethnic study. J Paediatr 1993; 123: 893-8.
4. Ragni MV, Bontempo FA, Cortese Hassett A. von Willebrand disease and bleeding in women. Hemophilia 1999; 5: 313-7.
5. Kouides PA. Menorrhagia from a haematologist's point of view. Part I: initial evaluation. Hemophilia 2002; 8: 330-8.
6. Kadir RA, Chi C. Women and von Willebrand disease: Controversies in diagnosis and management. Semi Thromb Hemost 2006; 32: 605-15.
7. Chen YC, Cheng SN, Chao TY, Tsai WT, Liang WC, Chiang JL. Clinical and laboratory studies of 25 patients with von Willebrand's disease in Taiwan. J Thromb Haemost 2005; 3(Suppl. 1): P2064.
8. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-5.
9. Rickles FR, Hoyer LW, Rick ME, Ahr DJ. The effects of epinephrine infusion in patients with von Willebrand disease. J Clin Invest 1976; 57: 1618-25.
10. Kadir RA, Economides DL, Sabin CA, Owens O, Lee CA. Variations in coagulation factors in women: Effects of age, ethnicity, menstrual cycle and combined oral contraceptive. Thromb Haemost 1999; 82: 1456-61.
11. Philipp CS, Dilley A, Miller CH, et al. Platelet functional defects in woman with unexplained menorrhagia. J Thromb Haemost 2003; 1: 477-84.
12. Olson JD, Brockway WJ, Fass DN, Magnuson MA, Walter Bowie EJ. Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation. Am J Clin Pathol 1975; 63: 210-8.
13. Francis J, Francis D, Larson L, Helms E, Garcia M. Can the platelet function analyzer (PFA)-100 test substitute for the template bleeding time in routine clinical practice? Platelets 1999; 10: 132-6.
14. Smejkal GB, Shainoff JR, Kottke-Marchant KM. Rapid high-resolution electrophoresis of multimeric von Willebrand factor using a thermopiloted gel apparatus. Electrophoresis 2003; 24: 582-7.
15. Lillicrap D, Nair SC, Srivastara A, Rodeghiero F, Pabingers I, Federici AB. Laboratory issues in bleeding disorder. Hemophilia 2006; 12(Suppl. 3): 68-75.
16. Edlund M, Blomback M, von Schoultz B, Andersson O. On the value of menorrhagia as a predictor for coagulation disorders. Am J Haematol 1996; 53: 234-8.
17. Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998; 351: 485-9.
18. Krause M, Aygoren-Pursun E, Ehrenforth S, Ludwig G, Vigh TH, Scharrer I. Coagulation disorders in women with menorrhagia. Haemophilia 2000; 6: 245.
19. Woo YL, White B, Corbally R et al. von Willebrand's disease: An important cause of dysfunctional uterine bleeding. Blood Coagul Fibrinol 2002; 13: 89-93.
20. Kouides P, Phatak P, Sham R et al. The prevalence of subnormal von Willebrand factor levels in menorrhagia patients in Rochester, NY: Final analysis. Haemophilia 2000; 6: 244.
21. Hambleton J, Roth J, Jurnack-Dewell J, Schwartz B, Seremetis S. Prevalence of unrecognized von Willebrand disease in women with menorrhagia: A preliminary report. Haemophilia 2000; 6: 242.
22. Dilley A, Drews C, Miller C et al. von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia. Obstet Gynecol 2001; 97: 630-6.
23. Goodman-Gruen D, Hollen bach K. The prevalence of von Willebrand disease in women with abnormal uterine bleeding. J Women Health Gend Based Med 2001; 10: 677-80.
24. El Ekiaby M, Ahmed A, Farag O, Khattab D. von Willebrand disease as a cause of menorrhagia. Haemophilia 2002; 8: 512.
25. Baindur S, Shetty S, Pathare AV, Salvi V, Ghosh K, Mohanty D. Screening for von Willebrand disease in patients with menorrhagia. Haemophilia 2000; 6: 240.
26. Kouides PA, Kadir RA. Menorrhagia associated with laboratory abnormalities of hemostasis: Epidemiology, diagnostic and therapeutic aspects. J Thromb Haemost 2007; 5(Suppl. 1): 175-82.
27. Preston FE. Laboratory diagnosis of hereditary bleeding disorders: external quality assessment. Haemophilia 1998; 4(Suppl. 2): 12-8.
28. Philipp CS, Miller CH, Faiz A et al. Screening women with menorrhagia for underlying bleeding disorders: The utility of the platelet function analyzer and bleeing time. Haemophilia 2005; 11: 497-503.